Davis Todd C

Ligand Pharmaceuticals Incorporated - Common Stock · Chief Executive Officer

Davis Todd C is listed in public filings as director, officer: Chief Executive Officer. This Davis Todd C insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Ligand Pharmaceuticals Incorporated - Common Stock (LGND), Pelthos Therapeutics Inc. (PTHS), Palvella Therapeutics, Inc. (PVLA), and Channel Therapeutics Corporation (CHRO). Investors use Davis Todd C's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Ligand Pharmaceuticals Incorporated - Common StockLGND	$10M50.1k shares	Grant / ExerciseMar 2, 2026	$10.1M50.1k shares	$202.55	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	--199.4k shares	Grant / ExerciseMar 2, 2026	Disclosure amount unavailable10.5k shares	--	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Ligand Pharmaceuticals Incorporated - Common StockLGND	$35M191.7k shares	Grant / ExerciseFeb 15, 2026	$782.2K4.3k shares	$183.83	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$35M188.9k shares	Grant / ExerciseFeb 15, 2026	$515.6K2.8k shares	$183.83	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$36M195.9k shares	Grant / ExerciseFeb 15, 2026	$374.8K2k shares	$183.83	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$36M198k shares	Grant / ExerciseFeb 14, 2026	$2.9M15.6k shares	$183.83	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$32M173.9k shares	Grant / ExerciseFeb 14, 2026	$1.5M8.2k shares	$183.83	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	--182.1k shares	Grant / ExerciseFeb 14, 2026	Disclosure amount unavailable20.8k shares	--	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	--213.6k shares	Grant / ExerciseFeb 14, 2026	Disclosure amount unavailable39.6k shares	--	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	--161.3k shares	Grant / ExerciseDec 4, 2025	Disclosure amount unavailable130 shares	--	--
Pelthos Therapeutics Inc.PTHS	$786k58.2k shares	Grant / ExerciseJul 2, 2025	$786.1K58.2k shares	$13.50	--
Pelthos Therapeutics Inc.PTHS	$499k37k shares	Grant / ExerciseJul 2, 2025	$258.0K19.1k shares	$13.50	--
Pelthos Therapeutics Inc.PTHS	--39.9k shares	Grant / ExerciseJul 2, 2025	Disclosure amount unavailable19.1k shares	--	--
Pelthos Therapeutics Inc.PTHS	$15M1.5M shares	Grant / ExerciseJul 1, 2025	$15.0M1.5M shares	$10.00	--
Pelthos Therapeutics Inc.PTHS	$31M3.1M shares	OtherJul 1, 2025	$312.8K31.3k shares	$10.00	--
Pelthos Therapeutics Inc.PTHS	$30k3k shares	Grant / ExerciseJul 1, 2025	$150.0K15k shares	$10.00	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$15M161.5k shares	OtherJun 30, 2025	$21.2K233 shares	$91.08	--
Palvella Therapeutics, Inc.PVLA	$324k12.4k shares	Grant / ExerciseJun 10, 2025	$323.9K12.4k shares	$26.23	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$17M161.2k shares	BuyMay 9, 2025	$583.6K5.5k shares	$105.67	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$16M155.7k shares	BuyMay 9, 2025	$241.2K2.3k shares	$104.53	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$16M153.4k shares	BuyMay 9, 2025	$175.7K1.7k shares	$104.57	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$11M93.5k shares	Grant / ExerciseMar 4, 2025	$10.8M93.5k shares	$115.26	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	--151.7k shares	Grant / ExerciseMar 4, 2025	Disclosure amount unavailable21.4k shares	--	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$16M130.3k shares	Grant / ExerciseFeb 15, 2025	$510.6K4.3k shares	$120.00	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$16M134.6k shares	Grant / ExerciseFeb 15, 2025	$267.7K2.2k shares	$120.00	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$16M136.8k shares	Grant / ExerciseFeb 14, 2025	$835.9K7k shares	$120.00	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	--143.8k shares	Grant / ExerciseFeb 14, 2025	Disclosure amount unavailable20.8k shares	--	--
Palvella Therapeutics, Inc.PVLA	$336k24.7k shares	Grant / ExerciseDec 13, 2024	$335.9K24.7k shares	$13.60	--
Pelthos Therapeutics Inc.PTHS	--20.8k shares	Grant / ExerciseNov 13, 2024	Disclosure amount unavailable5k shares	--	--
Channel Therapeutics CorporationCHRO	$169k263.3k shares	Grant / ExerciseNov 13, 2024	$31.7K49.6k shares	$0.64	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$12M123k shares	BuyAug 8, 2024	$243.5K2.5k shares	$97.39	--
Ligand Pharmaceuticals Incorporated - Common StockLGND	$7.3M120.5k shares	OtherJun 28, 2024	$21.2K350 shares	$60.71	--
Pelthos Therapeutics Inc.PTHS	--15.8k shares	Grant / ExerciseJun 14, 2024	Disclosure amount unavailable12.9k shares	--	--